Section of Immunology and Infection, Division of Applied Medicine, University of Aberdeen, Aberdeen, UK.
Transpl Int. 2013 Apr;26(4):453-61. doi: 10.1111/tri.12055. Epub 2013 Feb 11.
Models of high-risk corneal graft rejection involve neovascularization induced via innate immune responses, e.g., suture-mediated trauma. We describe a model of high-risk corneal graft rejection using corneal graft donor-recipient pairing based on a single-antigen disparity. Donor corneas from transgenic mice on B10.BR (H-2k ) background, in which hen-egg lysozyme (HEL) as a membrane-bound antigen (mHEL) was expressed under the major histocompatibility complex (MHC) class I promoter (KLK-mHEL, H-2k), were transplanted into wild type B10.BR recipient mice. Unmanipulated wild type recipient mice rejected KLK-mHEL grafts (39%) slowly over 50-60 days. Graft rejection incidence was maximized (100%) and tempo accelerated (27 days) by priming with HEL-pulsed syngeneic dendritic cells and less so by increasing T-cell precursor frequency. Rejection also reached maximum levels (100%) and tempo (3-8 days) when mice which had rejected a first graft ('rejectors') were regrafted, and was associated with induction of HEL-specific memory T cells. In contrast, 'acceptors' rejected a second graft at rates and tempo similar to naïve mice. These data reveal the importance of (i) donor MHC antigens as alloantigens for indirect recognition, (ii) alloantigen-specific memory in high-risk graft rejection involving regrafts, and (iii) suggest a role for tissue matching in human corneal graft to avoid sensitization to donor MHC antigens.
高危角膜移植排斥反应模型涉及先天免疫反应诱导的血管新生,例如缝线介导的创伤。我们描述了一种基于单一抗原差异的角膜移植物供体-受者配对的高危角膜移植排斥反应模型。供体角膜来自于在 B10.BR(H-2k)背景下的转基因小鼠,其中鸡卵溶菌酶(HEL)作为膜结合抗原(mHEL)在主要组织相容性复合体(MHC)I 类启动子(KLK-mHEL,H-2k)下表达。未处理的野生型 B10.BR 受体小鼠在 50-60 天内缓慢排斥 KLK-mHEL 移植物(39%)。通过用 HEL 脉冲同源树突状细胞进行预刺激,排斥发生率最大化(100%)且时间加快(27 天),而通过增加 T 细胞前体频率则效果稍差。当已经排斥第一移植物的小鼠(“排斥者”)再次移植时,排斥也达到了最高水平(100%)和时间(3-8 天),并伴随着 HEL 特异性记忆 T 细胞的诱导。相比之下,“接受者”以类似于未致敏小鼠的速率和时间再次排斥第二移植物。这些数据揭示了以下几点的重要性:(i)供体 MHC 抗原作为间接识别的同种异体抗原;(ii)同种异体抗原特异性记忆在涉及再移植的高危移植物排斥反应中的作用;(iii)提示组织匹配在避免对供体 MHC 抗原致敏方面在人类角膜移植中的作用。